Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

ICU Medical (ICUI) and Otsuka are launching a joint venture focused on boosting IV solutions production and development in North America. Read more here.

YARMOUTH, Maine – A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy solutions, says Connie Sullivan of the National Home Infusion ...

Baxter, a health care solutions manufacturer headquartered in Illinois, has been making progress on reopening one of its ...

The University of Rochester Medical Center (URMC) has resumed all surgeries, including elective procedures, following delays ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

The company has been trying to reinstate production at the plant, which makes 60% of the United States' supply of IV fluids and some key dialysis solutions, after it was closed in late September due ...